Avoidable emergency department (ED) use is one of the most practical outcome measures in IDD services because it sits at the intersection of safety, clinical coordination, staffing reliability, and effective daily support. The trap is treating ED visits as “random” or as a proxy for an individual’s needs. In reality, avoidable ED use often signals a preventable operational failure: missed deterioration, weak after-hours coverage, medication errors, or escalation confusion. For providers building defensible outcomes under IDD outcomes and impact resources and aligning delivery with IDD service models and pathways guidance, ED use becomes a credible indicator only when it is tied to definitions, workflows, and evidence that stand up to funder review.
Start with a definition funders will accept
“Reduce ED visits” is not a defensible goal on its own. Commissioners and Medicaid reviewers typically want to know whether ED use is avoidable, clinically appropriate, or driven by access barriers. A workable definition separates visits into categories the service can influence:
- Potentially avoidable ED use: issues that could reasonably be managed through planned supports, rapid clinical advice, early escalation, or better risk controls (e.g., dehydration, minor infections, preventable injuries, medication side effects recognized late).
- Clinically appropriate ED use: events where ED attendance is appropriate regardless of support quality (e.g., suspected stroke, major trauma, severe allergic reaction, uncontrolled seizures not responding to rescue medication per plan).
- Access-driven ED use: ED used because of service access gaps (e.g., inability to reach urgent care, no after-hours clinical advice, lack of transportation, or a provider handoff failure).
This structure allows you to show that your intent is not “avoid care,” but “get the right care in the right setting with the right response time.”
Two oversight expectations you should design for
Expectation 1: Oversight teams will expect an auditable trail. In many states, HCBS quality oversight focuses on whether critical events are identified, reviewed, and used for improvement. If ED visits are frequent, reviewers may look for evidence of risk assessment updates, incident follow-up, and care coordination—not just counts.
Expectation 2: Funders will expect outcome claims to be tied to service design. When you claim “reduced avoidable ED use,” payers often expect to see staffing patterns, after-hours escalation, and clinical coordination arranged to produce that outcome. If your model relies on on-call coverage, they will expect it to be consistently available, trained, and used—and that exceptions are reviewed.
Measure what you can actually influence
Avoidable ED reduction is a system outcome, but it must be built from operational measures leaders can act on. Practical supporting measures include: time from first symptom to escalation, time to clinician advice, completion of post-event reviews, medication reconciliation completion, and repeat ED use within 7–14 days for similar presentations. These process measures often become the “proof” that the system is under control, even when totals fluctuate month to month.
Operational Example 1: Early deterioration escalation for “small changes”
What happens in day-to-day delivery
Frontline staff use a simple deterioration checklist embedded into daily notes: appetite/fluid intake, sleep disruption, behavior change, pain indicators, toileting changes, and observed mobility changes. When thresholds are met (for example, reduced intake plus lethargy), staff follow a defined escalation ladder: notify shift lead, contact the on-call nurse/clinician (or contracted clinical advice line), and record the guidance in the person’s record. If ED is advised, the staff prepare a brief “ED handoff pack” containing current medications, allergies, baseline communication, and the reason for attendance.
Why the practice exists (failure mode it addresses)
Many avoidable ED visits start with subtle changes that are noticed but not escalated because staff lack confidence, worry about “overreacting,” or cannot reach the right decision-maker. This creates a delay until symptoms become urgent—often outside normal hours—when ED becomes the only available option.
What goes wrong if it is absent
Without structured escalation triggers, staff rely on inconsistent judgment. Deterioration is documented as “not themselves” without action. By the time the issue is recognized as serious, the person may be significantly unwell or distressed, requiring ED assessment and sometimes admission. Families and funders experience this as preventable, and the provider cannot evidence that timely steps were taken.
What observable outcome it produces
You see measurable improvements: shorter time-to-escalation, increased use of urgent care/telehealth in place of ED for minor conditions, fewer repeat ED visits for similar presentations, and stronger audit defensibility because records show a consistent decision pathway. Internal reviews can quantify “trigger-to-action” compliance and link improvements to reductions in potentially avoidable ED visits.
Operational Example 2: Medication side-effect and interaction monitoring after changes
What happens in day-to-day delivery
Whenever a medication is started, stopped, or adjusted, the manager schedules a time-limited monitoring plan (often 7–14 days) with specific observations: sedation level, agitation changes, falls risk, appetite, constipation, and seizure threshold indicators where relevant. Staff are briefed in handover, monitoring prompts appear in shift notes, and the clinical lead reviews data every 48–72 hours. If concerning patterns emerge, the provider contacts the prescriber/pharmacy for advice and documents the decision, rather than waiting for an acute episode.
Why the practice exists (failure mode it addresses)
Medication changes are a common driver of avoidable ED use—particularly when side effects mimic acute illness or when interactions produce behavioral escalation, falls, or dehydration. The failure mode is “change happens, nobody tracks the impact,” so early warning signs are missed.
What goes wrong if it is absent
Without structured monitoring, staff normalize sedation or agitation as “mood,” constipation becomes severe, or falls increase without a link to the medication timeline. The first time leadership learns of the issue may be after an injury or acute presentation leading to ED attendance. The provider then lacks evidence of proactive oversight, which is a major weakness in reviews.
What observable outcome it produces
Outcomes become visible in both safety and utilization: fewer medication-related incidents escalating to ED, reduced falls requiring medical assessment, and fewer crisis presentations linked to untreated side effects. Governance teams can track the percentage of medication changes with completed monitoring plans and demonstrate improvement over time.
Operational Example 3: Post-ED “return home” stabilization and recurrence prevention
What happens in day-to-day delivery
After any ED visit, the provider runs a structured “return home” huddle within 24–48 hours involving the manager, key staff, the individual where possible, and family/guardian if appropriate. The huddle confirms discharge instructions, updates risk controls, and assigns actions: follow-up appointments scheduled, new medication added to administration records, environmental adjustments made, and specific monitoring tasks set for the next week. A short debrief note is filed and flagged for quality review if the visit was potentially avoidable.
Why the practice exists (failure mode it addresses)
Repeat ED use often happens because discharge instructions are misunderstood, medication changes are not integrated correctly, or staff do not understand warning signs in that person’s context. The failure mode is weak transition back into routine support, where the same issue reoccurs within days.
What goes wrong if it is absent
Discharge papers sit in a folder without being translated into daily practice. Follow-up appointments are missed, medication changes are applied inconsistently across shifts, and warning signs are not monitored. The person cycles back to ED, which looks like “high need” but is frequently “low reliability,” triggering scrutiny and fear-driven practice.
What observable outcome it produces
Providers can evidence reduced repeat ED visits within 7–14 days for the same cause, improved compliance with discharge instructions, and fewer medication administration errors post-discharge. The audit trail shows learning and action: clear ownership, completion dates, and updated risk controls tied to the event.
Governance: turn ED events into improvement, not blame
To make ED reduction credible, providers need routine governance: monthly review of ED attendances, classification into avoidable/appropriate/access-driven, and a “top three causes” analysis with actions assigned. Quality teams should sample records for escalation compliance and confirm learning is translated into training and supervision. This is where the system-level story becomes defensible: not perfection, but control, learning, and measurable improvement.
How to report impact without distorting rights
Funders will challenge any approach that appears to discourage ED use when ED is clinically appropriate. Strong reporting explicitly states the goal is right-time care and includes safeguards: evidence that staff escalate early, not delay; evidence that restrictive practices are not used as a substitute for clinical support; and evidence that families/guardians are informed appropriately. When this balance is visible, ED utilization becomes a meaningful indicator of service quality rather than a headline metric.